⌘K

t

RNS Metadata

Date	2 Jan 2024
Time	07:30:00
Category	Corporate updates
ID	2206Y

/Equities/AIMX/AGY/RNS

Suspension - Allergy Therapeutics plc

RNS Number : 2206Y

AIM

02 January 2024

NOTICE

02/01/2024 7:30am

TEMPORARY SUSPENSION OF TRADING ON AIM

ALLERGY THERAPEUTICS PLC

At the request of the company trading on AIM for the under-mentioned securities has been temporarily suspended from 02/01/2024 7:30am, pending publication of the Company's annual audited accounts.

ORDINARY SHARES OF 0.1P EACH, FULLY PAID

(B02LCQ0) (GB00B02LCQ05)

If you have any queries relating to the above, please contact the company's nominated adviser on +44 (0)20 7886 2500.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

EXCTLBMTMTITBRJ

RNS Metadata

Date	2 Jan 2024
Time	07:30:00
Category	Corporate updates
ID	2206Y

RNS Number : 2206Y

AIM

02 January 2024

NOTICE

02/01/2024 7:30am

TEMPORARY SUSPENSION OF TRADING ON AIM

ALLERGY THERAPEUTICS PLC

At the request of the company trading on AIM for the under-mentioned securities has been temporarily suspended from 02/01/2024 7:30am, pending publication of the Company's annual audited accounts.

ORDINARY SHARES OF 0.1P EACH, FULLY PAID

(B02LCQ0) (GB00B02LCQ05)

If you have any queries relating to the above, please contact the company's nominated adviser on +44 (0)20 7886 2500.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

EXCTLBMTMTITBRJ

TIDM	AGY
Share Price	Loading...
Market Cap	Loading...

TIDM	AGY
Share Price	Loading...
Market Cap	Loading...

t

t

Company Information

RNS Metadata

Suspension - Allergy Therapeutics plc

Company Information

RNS Metadata